Key Segmentation:
By Valve
-
Transcatheter Heart Valves
-
Bioprosthetic (Tissue) Valves
-
Mechanical Valves
By Material
-
Biological Tissue
-
Pyrolytic Carbon
-
Metal Alloys
-
Polymers
By End Use
-
Hospitals
-
Ambulatory Surgical Centers
-
Other End Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Artivion Inc., MicroPort Scientific Corporation, Meril Life Sciences, and LivaNova PLC, among others.
Key opportunities include expanding transcatheter valve indications for mitral and tricuspid diseases, AI-assisted implantation systems, and manufacturer expansion across emerging Asia Pacific and Latin American markets.
The primary growth factor is the rising global prevalence of valvular heart disease among an expanding aging population, which is driving demand for both surgical and transcatheter valve replacement procedures.
By valve, the Transcatheter Heart Valves segment dominates the Prosthetic Heart Valve Market with approximately 47.50% share in 2025.
North America dominates the Prosthetic Heart Valve Market with approximately 45.00% share in 2025.
